MedTrace Logo

the Dietary Effects of VitaSugar/VitaFiber-IMO in Healthy Adults

NCT01462331 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-07-26

No results posted yet for this study

Summary

The purpose of this study is to re-confirm the already established health effects and dose tolerance of Isomalto-oligosaccharide or IMO, which is a general health/functional food ingredient.

Conditions

  • Healthy

Interventions

OTHER

Isomaltooligosaccharide (digestion-resistant carbohydrates)

12g/dose; three times a day

OTHER

Isomaltooligosaccharide (digestion-resistant carbohydrates)

18g/dose, three times a day

OTHER

Sucrose

12g/dose, three times a day

Sponsors & Collaborators

  • Alberta Agriculture and Rural Development

    collaborator UNKNOWN

  • BioNeutra Inc.

    lead OTHER

Principal Investigators

  • Mal Evans, PhD · KGK Synergize

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-11-30
Completion
2011-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01462331 on ClinicalTrials.gov